The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction

International Journal of Impotence Research

Volumn 19, Issue 2, 2007, Pages 149-153

  Peskircioglu, L ^a   Atac, F B ^a   Erdem, S R ^a   Deveci, S ^a   Verdi, H ^a   Ozkardes H ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Erectile dysfunction; Gene polymorphism; Genetics; Molecular biology; Oral treatment; Sildenafil

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; SILDENAFIL; TESTOSTERONE;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA ISOLATION; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; FREQUENCY ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; ORGANIC IMPOTENCE; PHARMACOGENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOGENIC IMPOTENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADULT; AGED; CASE-CONTROL STUDIES; HUMANS; IMPOTENCE; INTRONS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POLYMORPHISM, GENETIC; PURINES; SULFONES;

EID: 33847394947     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901501     Document Type: Article

References (19)

1. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5-11.
2. Murray FT, Geisser M, Murphy TC. Evaluation and treatment of erectile dysfunction. Am J Med Sci 1995; 309: 99-109.
3. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 31: 843-850.
4. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90-94.
5. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiological mediator of penile erection. Science 1992; 257: 401-403.
6. Rajasekaran M, Mondal D, Agrawal K, Chen IL, Hellstrom W, Sikka S. Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol 1998; 160: 2210-2215.
7. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J Cyclic Nucleotide Res 1979; 5: 211-224.
8. Ignarro LJ. Introduction and overview. In: Ignarro LJ (ed). Nitric oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 1-19.
9. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-1404.
10. Masters BS. Structural variations to accommodate functional themes of the isoforms of NO synthases. In: Ignarro LJ (ed). Nitric Oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 91-104.
11. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326.
12. Eisenhardt A, Sperling H, Hauck E, Porst H, Stief C, Rubben C et al. ACE gene I/D and NOS 3 G 894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology 2003; 62: 152-157.
13. Miller SA, Dykes DD, Polesky HS. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1998; 20: 1433-1440.
14. Yoon Y, Song J, Hong S, Kim J. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626-1630.
15. Vernet D, Cai L, Garban H, Babbitt ML, Murray FT, Rajfer J et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709-5717.
16. De Meyer GRY, Herman AG. Nitric oxide and vascular endothelial dysfunction. In: Ignarro LJ (ed). Nitric oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 547-567.
17. Balligand JL, Feron O, Kelly RA. Role of nitric oxide in myocardial function. In: Ignarro LJ (ed). Nitric Oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 585-607.
18. Wegner HE, Knispel HH, Klan R, Miller K. Efficacy of linsidomine chlorohydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial. Int J Impot Res 1995; 7: 233-237.
19. Moody JA, Vernet D, Laidlaw S, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term oral administration of L-arginine on the rat erectile response. J Urol 1997; 158: 942-947.